BosterBio | Antibodies, ELISA kits, Detection Kits Dr. Booster

CTLA4 Signaling Pathway

CTLA4 (cytotoxic T-lymphocyte–associated antigen 4, aka CD152) is a transmembrane protein member of the immunoglobin superfamily. This protein receptor plays a key role in downregulating immune responses (e.g. inhibit T-cell activation). Its expression relies on the stimulation of TCR and the binding between CD28 and B7 (B7-1/CD80 & B7-2/CD86), which both promote T-cell activation. Stimulating signals from TCR and CD28-B7 binding release CTLA4 from vesicles and translocates CTLA4 to the cell membrane where CTLA4 undergoes dimerization. Since CTLA4 has a much higher affinity for B7, this competitive binding could prevent signals from CD28-B7 binding. CTLA4 may also inhibit T-cell activation through the dephosphorylation of TCR-signaling proteins or the interference with Akt signaling.

Click below to download the CTLA4 pathway map PDF. Or access our entire catalog of pathway maps online.

Download now
CTLA4 Signaling Pathway
All Pathway Maps Access Now

Why Boster?

Get better results with Boster!
Boster takes great measures to ensure product quality and to provide our customers with comprehensive data upfront. Our antibodies are validated using WB, IHC, and flow cytometry against a panel of over 250 tissues and un-transfected cell lines to ensure high affinity and crystal-clear IHC stains. In addition, we also validate our antibodies in a quantitative fashion by testing them on known quantities of recombinant proteins so that you know what to expect (e.g. if there is 1ng, 2.5ng or 5ng of the target protein in the sample). Every product is covered by the Boster Quality Guarantee, click below to learn more.
Learn More

Supporting Our Customers

Have questions? We're here to help.
Contact Us
BosterBio | Antibodies, ELISA kits, Detection Kits Boster Biological Technology
3942 B Valley Ave, Pleasanton, CA, 94566

Email: [email protected]
Office: 888.466.3604
Follow us on Facebook Follow us on Twitter Follow us on LinkedIn
© 2018. All rights reserved
Unsubscribe from list